The clinical nutrition market refers to the industry that produces and markets specialized nutritional products and supplements for individuals with specific health conditions or those in need of medical nutrition therapy. These products are designed to provide essential nutrients to the body, including proteins, carbohydrates, fats, vitamins, and minerals, in appropriate proportions. Clinical nutrition products are used in various healthcare settings, such as hospitals, nursing homes, and home healthcare, to treat various medical conditions, including malnutrition, gastrointestinal disorders, cancer, and metabolic disorders. These products are typically prescribed by healthcare professionals, including dietitians and nutritionists.
The global clinical nutrition market is a growing industry, with increasing demand for specialized nutritional products due to rising incidences of chronic diseases, an aging population, and the increasing prevalence of malnutrition. The market is highly competitive, with many large and small players competing for market share. Key players in the clinical nutrition market include Abbott Laboratories, Nestle Health Science, Danone Nutricia, Baxter International, and Perrigo Nutritionals, among others.
The clinical nutrition market includes a wide range of products, including infant formula, enteral nutrition, parenteral nutrition, and dietary supplements. The market is segmented based on product type, route of administration, and application. The key factors driving the growth of the clinical nutrition market include the increasing incidence of chronic diseases, rising healthcare costs, and growing demand for personalized nutrition solutions.
According to the report, the global clinical nutrition industry generated $31.35 billion in 2018, and is estimated to reach $55.25 billion by 2026, witnessing a CAGR of 5.3% from 2019 to 2026.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/861
Drivers, restraints, and opportunities
Rise in prevalence of chronic disorders, surge in number of patients utilizing advanced clinical nutritional products, and increase in R&D investments by governments in the healthcare sector drive the growth of the global clinical nutrition market. However, lack of awareness and strict regulations restrain the market growth. On the other hand, advancements in clinical nutrition and untapped potential in emerging countries offer new opportunities in the coming years.
Procure Complete Report (220 Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.alliedmarketresearch.com/checkout-final/7d1dddce3aa3a2fbce5165eff6c47bb1
COVID-19 Scenario:
The governing authorities such as WHO, ESPEN, ASPEN, and others have released guidelines regarding nutritional assessment and screening of hospitalized Covid-19 patients.
Nutrition therapy based on guidelines and recommendations by authorities has been carried out for all the patients. It involves determining the requirement of water, protein, and energy for the individuals and providing them in required quantities to ensure nutritional adequacy.
The oral segment to maintain its lead position by 2026
Based on route of administration, the oral segment contributed to nearly half of the total share of the global clinical nutrition market in 2018, and is projected to maintain its lead position in terms of revenue during the forecast period. In addition, this segment is expected to witness the largest CAGR of 5.8% from 2019 to 2026. This is due to its widespread usage in patients as it offers ease in intake and convenience for treatment of several diseases. The report also offers a detailed analysis of segments including enteral and parenteral.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/861
North America to maintain its highest revenue contribution throughout the forecast period
Based on region, North America contributed to the largest share in terms of revenue in 2018, accounting for more than one-third of the total share of the global clinical nutrition market, and is estimated to maintain its highest contribution throughout the forecast period. This is due to rise in number of chronic disease including coronary artery disease, diabetes, ischemic stroke, and few cancer indications in the region. However, Asia-Pacific is expected to witness the fastest CAGR of 6.0% from 2019 to 2026, owing to rise in metabolic disorders and rise in patient awareness regarding adoption of clinical nutrition products.
Leading market players:
Abbott Laboratories
B. Braun Melsungen AG
Danone Nutricia
Baxter International Inc.
Fresenius SE & Co. KGaA
Perrigo Company Plc
Pfizer Inc.
Nestlé S.A
Lonza Ltd.
Hero Nutritionals Inc.
Other Trending Reports:
Long Read Sequencing Market
https://www.alliedmarketresearch.com/long-read-sequencing-market-A14421
Vascular Disease Devices Market
https://www.alliedmarketresearch.com/vascular-disease-devices-market-A15582
Contact Us:
David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.